Vivo Opportunity, LLC (CIK 0001728970)

Latest company ownership

Shares held
4,458,294
Last filed at
Mar 28, 2025
Confidence Score
49.6
2025Q4
Confidence Score History
2024Q2 2025Q4
Shares held
3,158,851
Last filed at
Jul 21, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q3 2025Q4
IOBT - IO Biotech, Inc.
Role: 10% Owner
Shares held
3,015,545
Last filed at
Aug 10, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2023Q3 2025Q4
Shares held
1,448,286
Last filed at
Nov 22, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q1 2025Q4
Shares held
268,573
Last filed at
Apr 3, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q1 2025Q4
Shares held
168,165
Last filed at
Mar 11, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 26, 2025 Mar 28, 2025 SOLENO THERAPEUTICS INC 10% Owner Sell 15.0 -1,833,557 -29.14% ✗ $124.4M
Aug 27, 2024 Aug 29, 2024 SOLENO THERAPEUTICS INC 10% Owner Sell 15.0 -1,025,000 -14.01% ✗ $49.2M
Apr 29, 2024 May 1, 2024 SOLENO THERAPEUTICS INC 10% Owner Sell 15.0 -1,101,242 -13.08% ✗ $51.7M
Apr 1, 2024 Apr 3, 2024 Terns Pharmaceuticals, Inc. 10% Owner Sell 27.5 -420,663 -6.32% ✓ $2.8M
Nov 21, 2023 Nov 22, 2023 Bolt Biotherapeutics, Inc. 10% Owner Sell 52.5 -3,400 -0.09% ✗ $3.1K
Nov 16, 2023 Nov 20, 2023 Bolt Biotherapeutics, Inc. 10% Owner Sell 22.5 -86,054 -1.10% ✗ $79.9K
Aug 9, 2023 Aug 10, 2023 IO Biotech, Inc. 10% Owner Buy 100.0 +3,157,894 104.72% ✗ $6M
Dec 23, 2022 Dec 23, 2022 Terns Pharmaceuticals, Inc. 10% Owner Buy 100.0 +758,620 12.86% ✗ $5.5M
Sep 7, 2022 Sep 8, 2022 Terns Pharmaceuticals, Inc. 10% Owner Buy 100.0 +600,000 11.32% ✗ $2.2M
Aug 12, 2022 Aug 16, 2022 Terns Pharmaceuticals, Inc. 10% Owner Buy 100.0 +2,624,239 63.15% ✗ $7M
Feb 9, 2021 Feb 9, 2021 Bolt Biotherapeutics, Inc. 10% Owner Buy 96.3 +349,774 9.93% ✗ $7M
Feb 9, 2021 Feb 9, 2021 Terns Pharmaceuticals, Inc. 10% Owner Buy 100.0 +475,000 21.59% ✗ $8.1M
Jul 21, 2020 Jul 21, 2020 ALX ONCOLOGY HOLDINGS INC 10% Owner Buy 100.0 +975,000 100.00% ✗ $18.5M
Mar 9, 2020 Mar 11, 2020 Crinetics Pharmaceuticals, Inc. 10% Owner Sell 51.3 -528 -0.02% ✗ $10.3K
Feb 7, 2020 Feb 11, 2020 Crinetics Pharmaceuticals, Inc. 10% Owner Sell 37.5 -13,460 -0.21% ✗ $291.6K
Feb 4, 2020 Feb 6, 2020 Crinetics Pharmaceuticals, Inc. 10% Owner Sell 37.5 -13,460 -0.41% ✗ $306.9K
Jan 29, 2020 Jan 31, 2020 Crinetics Pharmaceuticals, Inc. 10% Owner Sell 37.5 -26,920 -0.27% ✗ $594.2K
Mar 20, 2019 Mar 25, 2019 Crinetics Pharmaceuticals, Inc. 10% Owner Sell 16.3 -417,000 -11.16% ✗ $9.3M
Jul 20, 2018 Jul 20, 2018 Crinetics Pharmaceuticals, Inc. 10% Owner Buy 100.0 +353,180 10.02% ✗ $6.6M